Fundraising Fox

Sensei Biotherapeutics

Rockville, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

KH
Kristian HumerExecutive
CG
Christopher GerryExecutive
AK
Anand Kiran ParikhExecutive
JC
Josiah CraverExecutive

Board

BH
Bob HolmenBoard director
PB
Phillip B. DonenbergBoard director
TR
Tom RicksBoard director

Investors · 1

Sofinnova VenturesMenlo Park · $100K – $15M

Reported raises · per SEC filings

Form D private placements

$348.9M disclosed across 1 round · 2026

▶$348.9MraisedMar 2026 · 104 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bob HolmenDirector
  • Kristian HumerDirector
  • Christopher GerryExecutive Officer, Director
  • Phillip B. DonenbergDirector
  • Anand Kiran ParikhExecutive Officer, Director
  • Tom RicksDirector
  • Josiah CraverExecutive Officer
Offering amount
$348.9M
Amount sold
$348.9M
Sales commissions
$11.7M
Finders' fees
$100K
Placement agents
Leerink Partners
First sale
Feb 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Faeth acquisition and $200M raise reshape Sensei Biotherapeutics (NASDAQ: SNSE)stocktitan.net · Mar 2026Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Solve PI3K Resistancehitconsultant.net · Feb 2026Sensei Biotherapeutics buys Faeth, raises $200M | SNSE 8-K Filingstocktitan.net · Feb 2026Sensei acquires Faeth, raises $200 million for cancer drug pipeline By Investing.cominvesting.com · Feb 2026

Frequently asked questions

Who are Sensei Biotherapeutics's investors?
Sensei Biotherapeutics's investors include Sofinnova Ventures.
How much funding has Sensei Biotherapeutics raised?
Sensei Biotherapeutics has disclosed $348.9M raised across 1 round.
Where is Sensei Biotherapeutics headquartered?
Sensei Biotherapeutics is headquartered in Rockville, US.